Review on the Long-Range Mediators of Oncogenic Signalling, Epigenetic Reprogramming, Metastasis, and Therapy Resistance in Microbiome-Cancer
UMYU Journal of Microbiology Research (UJMR) · 2026-07-07 · 11 (2) · 65-88
DOI: 10.47430/ujmr.26112.008 ↗At a glance
Journal article in UMYU Journal of Microbiology Research (UJMR), published online on 2026-07-07. Written by Yusuf Aliyu Munir and 6 co-authors. 93 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
The role of the microbiome in shaping cancer development, progression, and treatment outcomes has become increasingly recognised over the past decade. However, the mechanisms by which spatially distant microbial communities influence tumour progression remain underexplored and poorly understood. The persistence of strong tumour-modulating effects despite low microbial abundance suggests that cell-free mediators enable systemic communication. This review synthesises current evidence on microbial extracellular vesicles (MEVs), including bacterial outer membrane vesicles (OMVs) and fungal extracellular vesicles, as key long-range signalling entities linking the microbiota to cancer progression. A systematic search was conducted across PubMed, Web of Science, and Scopus. Studies published between 2010 and 2026 that investigated mechanistic EV-host interactions were included. Findings indicate that MEVs influence multiple cancer hallmarks. These include activation of oncogenic pathways (NF-κB, Wnt/β-catenin, MAPK, PI3K/AKT), induction of epigenetic alterations (DNA methylation, histone modification, and RNA-mediated regulation), and remodelling of the tumour microenvironment through immune modulation, such as macrophage polarisation and T-cell dysfunction. MEVs also promote epithelial-mesenchymal transition and contribute to therapeutic resistance. Distinct microbial cargoes, such as Helicobacter pyloriCagA-associated factors, Fusobacterium nucleatum FadA adhesins, and fungal β-glucans, exhibit cancer-type specificity, particularly in gastric, colorectal, and pulmonary malignancies. MEVs redefine the microbiome-cancer paradigm by shifting focus from microbial colonisation to microbial signalling. They function as molecular conveyors of oncogenic information, with implications for biomarker discovery and the development of microbiome-targeted cancer therapeutics.
Cite
APA
Munir, Y. A., Sajjad, F., Bashir, A., Musari, K. A., Magaji, M., Anas, A. T., & Aliyu, S. H. (2026). Review on the Long-Range Mediators of Oncogenic Signalling, Epigenetic Reprogramming, Metastasis, and Therapy Resistance in Microbiome-Cancer. UMYU Journal of Microbiology Research (UJMR), 11(2), 65-88. https://doi.org/10.47430/ujmr.26112.008
Vancouver
Munir YA, Sajjad F, Bashir A, Musari KA, Magaji M, Anas AT, et al. Review on the Long-Range Mediators of Oncogenic Signalling, Epigenetic Reprogramming, Metastasis, and Therapy Resistance in Microbiome-Cancer. UMYU Journal of Microbiology Research (UJMR). 2026;11(2):65-88. doi:10.47430/ujmr.26112.008
BibTeX
@article{Munir2026,
author = {Munir, Yusuf Aliyu and Sajjad, Fahad and Bashir, Abdulmajid and Musari, Khalid Audu and Magaji, Mannir and Anas, Asma’u Tukur and Aliyu, Suleiman Hayatulah},
title = {Review on the Long-Range Mediators of Oncogenic Signalling, Epigenetic Reprogramming, Metastasis, and Therapy Resistance in Microbiome-Cancer},
journal = {UMYU Journal of Microbiology Research (UJMR)},
year = {2026},
volume = {11},
number = {2},
pages = {65--88},
doi = {10.47430/ujmr.26112.008}
}
EUVIMED